| FP3 Fingerprint: |
0.81 |
| NHs/OHs: |
3 |
| Nitrogens and Oxygens: |
13 |
| Aliphatic Carbocycles: |
1 |
| Aliphatic Heterocycles: |
3 |
| Aliphatic Rings: |
4 |
| Aromatic Carbocycles: |
0 |
| Aromatic Heterocycles: |
0 |
| Aromatic Rings: |
0 |
| Heteroatoms: |
13 |
| Radical Electrons: |
0 |
| Saturated Carbocycles: |
1 |
| Saturated Heterocycles: |
2 |
| Saturated Rings: |
3 |
| Valence Electrons: |
318 |
| Rings: |
4 |
| Aliphatic Carboxylic Acids: |
0 |
| Aliphatic Hydroxyl Groups: |
3 |
| Aliphatic Hydroxyl Groups Excluding Tert-OH: |
2 |
| Nitrogen Functional Groups Attached to Aromatics: |
0 |
| Aromatic Carboxylic Acide: |
0 |
| Aromatic Nitrogens: |
0 |
| Aromatic Amines: |
0 |
| Aromatic Hydroxyl Groups: |
0 |
| Carboxylic Acids (COO): |
0 |
| Carboxylic Acids (COO2): |
0 |
| Carbonyl Oxygens: |
4 |
| Carbonyl Oxygens, excluding COOH: |
4 |
| Thiocarbonyls: |
0 |
| C(OH)CCN-Ctert-alkyls/C(OH)CCNcyclics: |
0 |
| Imines: |
0 |
| Tertiary Amines: |
1 |
| Secondary Amines: |
0 |
| Primary Amines: |
0 |
| Hydroxylamine Groups: |
0 |
| XCCNR Groups: |
0 |
| Tert-alicyclic Amines (no heteroatoms, not quinine-like bridged N): |
0 |
| H-pyrrole nitrogens: |
0 |
| Thiol groups: |
0 |
| Aldehydes: |
0 |
| Alkyl Carbamates (subject to hydrolysis): |
0 |
| Alkyl Halides: |
0 |
| Allylic Oxidation Sites excluding Steroid Dienone: |
3 |
| Amides: |
1 |
| Amidine Groups: |
0 |
| Anilines: |
0 |
| Aryl Methyl Sites for Hydroxylation: |
0 |
| Azide Groups: |
0 |
| Azo Groups: |
0 |
| Barbiturate Groups: |
0 |
| Benzene Rings: |
0 |
| Benzodiazepines with no additional Fused Rings: |
0 |
| Bicyclic: |
3 |
| Diazo Groups: |
0 |
| Dihydropyridines: |
0 |
| Epoxide Rings: |
0 |
| Esters: |
1 |
| Ether Oxygens (including phenoxy): |
5 |
| Furan Rings: |
0 |
| Guanidine Groups: |
0 |
| Halogens: |
0 |
| Hydrazine Groups: |
0 |
| Hydrazone Groups: |
0 |
| Imidazole Rings: |
0 |
| Imide Groups: |
0 |
| Isocyanates: |
0 |
| Isothiocyanates: |
0 |
| Ketones: |
2 |
| Ketones excluding diaryl, a,b-unsat. dienones, heteroatom on Calpha: |
2 |
| Beta Lactams: |
0 |
| Cyclic Esters (Lactones): |
1 |
| Methoxy Groups -OCH3: |
3 |
| Morpholine Rings: |
0 |
| Nitriles: |
0 |
| Nitro Groups: |
0 |
| Nitro Benzene Ring Substituents: |
0 |
| Non-ortho Nitro Benzene Ring Substituents: |
0 |
| Nitroso Groups, excluding NO2: |
0 |
| Oxazole Rings: |
0 |
| Oxime Groups: |
0 |
| Para-hydroxylation Sites: |
0 |
| Phenols: |
0 |
| Phenolic OH excluding Ortho Intramolecular Hbond substituents: |
0 |
| Phosphoric Acid Groups: |
0 |
| Phosphoric Ester Groups: |
0 |
| Piperdine Rings: |
1 |
| Piperzine Rings: |
0 |
| Primary Amides: |
0 |
| Primary Sulfonamides: |
0 |
| Pyridine Rings: |
0 |
| Guarternary Nitrogens: |
0 |
| Thioethers: |
0 |
| Sulfonamides: |
0 |
| Sulfone Groups: |
0 |
| Terminal Acetylenes: |
0 |
| Tetrazole Rings: |
0 |
| Thiazole Rings: |
0 |
| Thiocyanates: |
0 |
| Thiophene Rings: |
0 |
| Unbranched Alkanes of at least 4 members (excludes halogenated alkanes): |
0 |
| Urea Groups: |
0 |
| BCUT2D - Gasteiger Charge Eigenvalue High: |
2.56 |
| BCUT2D - Gasteiger Charge Eigenvalue Low: |
-2.47 |
| BCUT2D - Crippen Lowgp Eigenvalue High: |
2.39 |
| BCUT2D - Crippen Lowgp Eigenvalue Low: |
-2.64 |
| BCUT2D - Crippen MR Eigenvalue High: |
6.39 |
| BCUT2D - Crippen MR Eigenvalue Low: |
-0.30 |
| BCUT2D - Mass Eigenvalue High: |
16.66 |
| BCUT2D - Mass Eigenvalue Low: |
9.81 |
| Balaban’s J: |
1.76 |
| Bertz CT: |
1430.85 |
| Chi 0: |
41.48 |
| Chi 0n: |
35.11 |
| Chi 0v: |
35.11 |
| Chi 1: |
26.48 |
| Chi 1n: |
20.78 |
| Chi 1v: |
20.78 |
| Chi 2n: |
17.16 |
| Chi 2v: |
17.16 |
| Chi 3v: |
12.89 |
| Chi 3v: |
12.89 |
| Chi 4n: |
9.39 |
| Chi 4v: |
9.39 |
| Morgan Fingerprint Density (1): |
0.91 |
| Morgan Fingerprint Density (2): |
1.57 |
| Morgan Fingerprint Density (3): |
2.21 |
| CSP3 Fraction: |
0.81 |
| Hall Kier Alpha: |
-2.52 |
| Heavy Atoms: |
56.00 |
| Ipc descriptor: |
745099100000.00 |
| Kappa 1: |
46.17 |
| Kappa 2: |
20.44 |
| Kappa 3: |
10.75 |
| Labute ASA: |
333.02 |
| Max ABS Estate Index: |
14.28 |
| Max ABS Partial Charge: |
0.46 |
| Max Estate Index: |
14.28 |
| Max Partial Charge: |
0.33 |
| Minimal ABS Estate Index: |
0.00 |
| Minimal ABS Partial Charge: |
0.33 |
| Minimal State Index: |
-2.50 |
| Minimal Partial Charge: |
-0.46 |
| Molar Refractivity: |
208.07 |
| Quantitative Estimation of Drug-likeness (QED): |
0.20 |
